No Data
No Data
RBC Capital Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Maintains Target Price $65
Tandem Diabetes Care Inc (TNDM) Q2 2024 Earnings Call Highlights: Strong Sales Growth and ...
Medtronic Issues Recall for MiniMed Insulin Pumps Over Battery Issues
This MINISO Group Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Goldman Sachs Initiates Tandem Diabetes Care(TNDM.US) With Hold Rating, Announces Target Price $46
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Tandem Diabetes Care (TNDM) and BioMarin Pharmaceutical (BMRN)